サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1388187

血漿市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2032年

Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); By Application; By End-Use; By Region; Segment Forecast, 2023- 2032

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
血漿市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年10月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris market researchの最新調査によると、世界の血漿市場規模は2032年までに547億8,767万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

血漿市場は、特に血友病やサラセミアなどの重篤な血液疾患の有病率の増加により大幅な成長を遂げており、毎年何百人もの新生児に影響を及ぼしています。血漿は血液の液体成分であり、様々な血液成分の運搬に重要な役割を果たし、特に血液型がA.B.の人々から需要があります。血漿は熱傷、ショック、外傷、凝固障害の治療に使用され、血液量、ショック予防、凝固補助を助ける。製薬会社は出血性疾患や免疫不全の治療薬の製造に血漿を利用しています。

市場の拡大は、政府の取り組み、社会的認知度の向上、研究開発努力、ヘルスケアセクターの拡大、人口の高齢化、血漿由来製品の採用増加などが背景にあります。凝固第VIII因子や免疫グロブリンなどの血漿由来製品は、血液関連疾患の管理に不可欠です。先進的な血漿由来製品の研究開発、戦略的製造、技術の進歩、多くの患者基盤、ヘルスケア支出の増加はすべて、2022年から2032年の予測期間における市場のプラス成長に寄与しています。

血漿市場は、ヒト血漿に頼ることなく様々な病状に対する治療を提供する遺伝子組み換え代替品による混乱に直面しています。生物学的に設計されたタンパク質や凝固因子は組換え技術によって生産することができ、血漿への依存度を下げることができます。この競合は価格設定や市場シェアに影響を与える可能性があります。遺伝子組み換えの代替製品はより安全であると認識されており、特定の疾患や病状における血漿由来製品に関連する病原体伝播のリスクが排除されるからです。

血漿市場レポートハイライト

2022年の売上シェアは免疫グロブリンが45.4%を占め、免疫応答や自己免疫疾患・免疫不全症の治療に重要な役割を果たします。

免疫不全疾患分野は、2022年の売上高の28.7%を占め、主に免疫グロブリンのような血漿由来製品に依存して、様々な原発性免疫不全疾患を管理しています。

北米は、国際的な需要と公衆衛生への備えのために不可欠な血漿由来製品の供給において、2022年の世界市場45.5%のシェアを占めました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の血漿市場に関する洞察

  • 血漿- 業界スナップショット
  • 血漿市場力学
    • 促進要因と機会
      • 血漿由来療法の需要の高まり
      • 高齢者人口の増加が市場の成長を促進
    • 抑制要因と課題
      • 高コストと組換え代替品が市場の成長を妨げる
  • PESTEL分析
  • 血漿市場の業界動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の血漿市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • アルブミン
  • 第VIII因子
  • 第IX因子
  • 免疫グロブリン
  • 高度免疫グロブリン
  • その他

第6章 世界の血漿市場、用途別

  • 主な調査結果
  • イントロダクション
  • 血友病
  • 低ガンマグロブリン血症
  • 免疫不全疾患
  • フォン・ヴィレブランド病
  • その他

第7章 世界の血漿市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • クリニック
  • その他

第8章 世界の血漿市場、地域別

  • 主な調査結果
  • イントロダクション
    • 血漿市場評価、地域別、2019年～2032年
  • 血漿市場 - 北米
    • 北米：血漿市場、タイプ別、2019年～2032年
    • 北米：血漿市場、最終用途別、2019年～2032年
    • 北米：血漿市場、用途別、2019年～2032年
    • 血漿市場 - 米国
    • 血漿市場 - カナダ
  • 血漿市場 - 欧州
    • 欧州：血漿市場、タイプ別、2019年～2032年
    • 欧州：血漿市場、最終用途別、2019年～2032年
    • 欧州：血漿市場、用途別、2019年～2032年
    • 血漿市場 - 英国
    • 血漿市場 - フランス
    • 血漿市場 - ドイツ
    • 血漿市場 - イタリア
    • 血漿市場 - スペイン
    • 血漿市場 - オランダ
    • 血漿市場 - ロシア
  • 血漿市場 - アジア太平洋
    • アジア太平洋：血漿市場、タイプ別、2019年～2032年
    • アジア太平洋：血漿市場、最終用途別、2019年～2032年
    • アジア太平洋：血漿市場、用途別、2019年～2032年
    • 血漿市場 - 中国
    • 血漿市場 - インド
    • 血漿市場 - マレーシア
    • 血漿市場 - 日本
    • 血漿市場 - インドネシア
    • 血漿市場 - 韓国
  • 血漿市場 - 中東・アフリカ
    • 中東・アフリカ：血漿市場、タイプ別、2019年～2032年
    • 中東・アフリカ：血漿市場、最終用途別、2019年～2032年
    • 中東・アフリカ：血漿市場、用途別、2019年～2032年
    • 血漿市場 - サウジアラビア
    • 血漿市場 - アラブ首長国連邦
    • 血漿市場 - イスラエル
    • 血漿市場 - 南アフリカ
  • 血漿市場 - ラテンアメリカ
    • ラテンアメリカ：血漿市場、タイプ別、2019年～2032年
    • ラテンアメリカ：血漿市場、最終用途別、2019年～2032年
    • ラテンアメリカ：血漿市場、用途別、2019年～2032年
    • 血漿市場 - メキシコ
    • 血漿市場 - ブラジル
    • 血漿市場 - アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Biotest AG
  • CSL
  • GC Biopharma Corp
  • Grifols
  • Intas Pharmaceuticals Ltd
  • Kedrion S.p.A.
  • LFB
  • Octapharma AG
  • Sanquin
  • Takeda Pharmaceuticals
図表

List of Tables

  • Table 1 Global Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 2 Global Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 3 Global Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 4 Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Table 5 North America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 6 North America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 7 North America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 8 U.S.: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 9 U.S.: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 10 U.S.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 11 Canada: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 12 Canada: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 13 Canada: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 14 Europe: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 15 Europe: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 16 Europe: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 17 UK: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 18 UK: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 19 UK: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 20 France: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 21 France: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 22 France: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 23 Germany: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 24 Germany: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 25 Germany: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 26 Italy: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 27 Italy: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 28 Italy: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 29 Spain: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 30 Spain: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 31 Spain: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 32 Netherlands: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 33 Netherlands: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 34 Netherlands: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 35 Russia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 36 Russia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 37 Russia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 38 Asia Pacific: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 39 Asia Pacific: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 40 Asia Pacific: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 41 China: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 42 China: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 43 China: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 44 India: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 45 India: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 46 India: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 47 Malaysia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 48 Malaysia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 49 Malaysia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 50 Japan: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 51 Japan: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 52 Japan: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 53 Indonesia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 54 Indonesia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 55 Indonesia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 56 South Korea: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 57 South Korea: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 58 South Korea: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 59 Middle East & Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 60 Middle East & Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 61 Middle East & Africa: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 62 Saudi Arabia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 63 Saudi Arabia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 64 Saudi Arabia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 65 UAE: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 66 UAE: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 67 UAE: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 68 Israel: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 69 Israel: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 70 Israel: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 71 South Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 72 South Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 73 South Africa: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 74 Latin America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 75 Latin America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 76 Latin America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 77 Mexico: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 78 Mexico: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 79 Mexico: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 80 Brazil: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 81 Brazil: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 82 Brazil: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 83 Argentina: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 84 Argentina: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 85 Argentina: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)

List of Figures

  • Figure 1. Global Blood Plasma Market, 2019 - 2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Blood Plasma Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Blood Plasma Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global Blood Plasma Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 12. Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Figure 13. Strategic Analysis - Blood Plasma Market
目次
Product Code: PM1311

The global blood plasma market size is expected to reach USD 54,787.67 million by 2032, according to a new study by Polaris market research. The report "Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); By Application; By End-Use; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blood plasma market is experiencing substantial growth due to the increasing prevalence of severe blood disorders, notably Hemophilia and Thalassemia, impacting hundreds of newborns annually. Blood plasma, the fluid component of blood, plays a crucial role in transporting various blood constituents and is particularly in demand from individuals with blood type A.B. It is used in treating burn, shock, trauma, and clotting disorders, aiding in blood volume, shock prevention, and clotting support. Pharmaceutical companies utilize plasma for producing treatments for bleeding disorders and immune deficiencies.

The market's expansion is driven by government initiatives, growing public awareness, research and development efforts, healthcare sector expansion, an aging population, and increased adoption of plasma-derived products. Plasma-derived products like coagulation factor VIII and immunoglobulins are essential for managing blood-related disorders. Research and development in advanced plasma-derived products, strategic manufacturing, technological advancements, a substantial patient base, and increased healthcare expenditure all contribute to the market's positive trajectory during the 2022 to 2032 forecast period.

The blood plasma market faces disruption from recombinant alternatives that offer treatments for various medical conditions without relying on human plasma. Biologically engineered proteins and clotting factors can be produced through recombinant technologies, reducing dependence on plasma. This competition can impact pricing and market share, as recombinant alternatives are perceived as safer, eliminating the risk of pathogen transmission associated with plasma-derived products in specific diseases and medical conditions.

Blood Plasma Market Report Highlights

Immunoglobulins dominated with 45.4% revenue share in 2022, serving vital roles in immune responses and treating autoimmune and immunodeficiency disorders.

Immunodeficiency Diseases segment accounted for 28.7% of revenue in 2022, primarily relying on blood plasma-derived products, like immunoglobulins, to manage various primary immunodeficiency disorders.

North America led the 2022 global market 45.5% share in supplying plasma-derived products, vital for international demand and public health preparedness.

The global key market players include: Biotest AG, CSL, GC Biopharma Corp, Grifols, Intas Pharmaceuticals Ltd, Kedrion S.p.A., LFB, Octapharma AG, Sanquin, Takeda Pharmaceuticals

Polaris market research has segmented the Blood Plasma market report based on Type, Application, End-User, and region:

Blood Plasma, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Blood Plasma, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Hemophilia
  • Hypogammaglobinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others

Blood Plasma, End-User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Clinics
  • Others

Blood Plasma, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Blood Plasma Market Insights

  • 4.1. Blood Plasma - Industry Snapshot
  • 4.2. Blood Plasma Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Plasma-Derived Therapies
      • 4.2.1.2. Growing Geriatric Population Fuels the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost and Recombinant Alternatives Hampers the Growth of the Market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Blood Plasma Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Blood Plasma Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • 5.3. Albumin
    • 5.3.1. Global Blood Plasma Market, by Albumin, by Region, 2019 - 2032 (USD Million)
  • 5.4. Factor VIII
    • 5.4.1. Global Blood Plasma Market, by Factor VIII, by Region, 2019 - 2032 (USD Million)
  • 5.5. Factor IX
    • 5.5.1. Global Blood Plasma Market, by Factor IX, by Region, 2019 - 2032 (USD Million)
  • 5.6. Immunoglobulin
    • 5.6.1. Global Blood Plasma Market, by Immunoglobulin, by Region, 2019 - 2032 (USD Million)
  • 5.7. Hyperimmune Globulin
    • 5.7.1. Global Blood Plasma Market, by Hyperimmune Globulin, by Region, 2019 - 2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Other Blood Plasma Market, by Region, 2019 - 2032 (USD Million)

6. Global Blood Plasma Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 6.3. Hemophilia
    • 6.3.1. Global Blood Plasma Market, by Hemophilia, by Region, 2019 - 2032 (USD Million)
  • 6.4. Hypogammaglobulinemia
    • 6.4.1. Global Blood Plasma Market, by Hypogammaglobulinemia, by Region, 2019 - 2032 (USD Million)
  • 6.5. Immunodeficiency Diseases
    • 6.5.1. Global Blood Plasma Market, by Immunodeficiency Diseases, by Region, 2019 - 2032 (USD Million)
  • 6.6. Von Willebrand's Disease
    • 6.6.1. Global Blood Plasma Market, by Von Willebrand's Disease, by Region, 2019 - 2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Blood Plasma Market, by Other Applications, by Region, 2019 - 2032 (USD Million)

7. Global Blood Plasma Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Blood Plasma Market, by Hospitals, by Region, 2019 - 2032 (USD Million)
  • 7.4. Clinics
    • 7.4.1. Global Blood Plasma Market, by Clinics, by Region, 2019 - 2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Other Blood Plasma Market, by Region, 2019 - 2032 (USD Million)

8. Global Blood Plasma Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • 8.3. Blood Plasma Market - North America
    • 8.3.1. North America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.3.2. North America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.3.3. North America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.4. Blood Plasma Market - U.S.
      • 8.3.4.1. U.S.: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.4.2. U.S.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.3.4.3. U.S.: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.5. Blood Plasma Market - Canada
      • 8.3.5.1. Canada: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.5.2. Canada.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.3.5.3. Canada: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.4. Blood Plasma Market - Europe
    • 8.4.1. Europe: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.4.2. Europe.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.4.3. Europe: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.4. Blood Plasma Market - UK
      • 8.4.4.1. UK: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.4.2. UK.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.4.3. UK: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.5. Blood Plasma Market - France
      • 8.4.5.1. France: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.5.2. France.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.5.3. France: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.6. Blood Plasma Market - Germany
      • 8.4.6.1. Germany: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.6.2. Germany.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.6.3. Germany: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.7. Blood Plasma Market - Italy
      • 8.4.7.1. Italy: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.7.2. Italy.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.7.3. Italy: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.8. Blood Plasma Market - Spain
      • 8.4.8.1. Spain: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.8.2. Spain.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.8.3. Spain: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.9. Blood Plasma Market - Netherlands
      • 8.4.9.1. Netherlands: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.9.2. Netherlands.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.9.3. Netherlands: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.10. Blood Plasma Market - Russia
      • 8.4.10.1. Russia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.10.2. Russia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.10.3. Russia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.5. Blood Plasma Market - Asia Pacific
    • 8.5.1. Asia Pacific: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.5.2. Asia Pacific.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.5.3. Asia Pacific: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.4. Blood Plasma Market - China
      • 8.5.4.1. China: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.4.2. China.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.4.3. China: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.5. Blood Plasma Market - India
      • 8.5.5.1. India: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.5.2. India.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.5.3. India: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.6. Blood Plasma Market - Malaysia
      • 8.5.6.1. Malaysia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.6.2. Malaysia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.6.3. Malaysia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.7. Blood Plasma Market - Japan
      • 8.5.7.1. Japan: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.7.2. Japan.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.7.3. Japan: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.8. Blood Plasma Market - Indonesia
      • 8.5.8.1. Indonesia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.8.2. Indonesia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.8.3. Indonesia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.9. Blood Plasma Market - South Korea
      • 8.5.9.1. South Korea: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.9.2. South Korea.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.9.3. South Korea: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.6. Blood Plasma Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.6.3. Middle East & Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.4. Blood Plasma Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.5. Blood Plasma Market - UAE
      • 8.6.5.1. UAE: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.5.2. UAE.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.5.3. UAE: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.6. Blood Plasma Market - Israel
      • 8.6.6.1. Israel: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.6.2. Israel.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.6.3. Israel: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.7. Blood Plasma Market - South Africa
      • 8.6.7.1. South Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.7.2. South Africa.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.7.3. South Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.7. Blood Plasma Market - Latin America
    • 8.7.1. Latin America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.7.2. Latin America.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.7.3. Latin America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.4. Blood Plasma Market - Mexico
      • 8.7.4.1. Mexico: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.4.2. Mexico.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.4.3. Mexico: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.5. Blood Plasma Market - Brazil
      • 8.7.5.1. Brazil: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.5.2. Brazil.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.5.3. Brazil: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.6. Blood Plasma Market - Argentina
      • 8.7.6.1. Argentina: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.6.2. Argentina.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.6.3. Argentina: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biotest AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. CSL
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. GC Biopharma Corp
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Grifols
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Intas Pharmaceuticals Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Kedrion S.p.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. LFB
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Octapharma AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanquin
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Takeda Pharmaceuticals
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development